Maykin Ho

Maykin Ho is a highly experienced board member and venture partner with extensive expertise in the healthcare and biotechnology sectors. Current board roles include positions at Neumora, BioMarin Pharmaceutical Inc., FibroGen, PAREXEL, and Agios Pharmaceuticals, among others. Maykin also serves as a venture partner at Qiming Venture Partners and as a partner at Viridian Global LLC. Previous experience includes advisory roles at Goldman Sachs in healthcare investment banking and strategic planning at DuPont Merck Pharmaceutical Company. Educational credentials include a Postdoctoral Fellowship in Immunology from Harvard Medical School.